AJCN Tufts Nutrition Symposium, Boston & Online Sept 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Clin Nutr 89: 27-36, 2009. First published December 3, 2008; doi:10.3945/ajcn.2008.26299
American Journal of Clinical Nutrition, doi:10.3945/ajcn.2008.26299
Vol. 89, No. 1, 27-36, January 2009

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
89/1/27    most recent
ajcn.2008.26299v1
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Straznicky, N. E
Right arrow Articles by Lambert, E. A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Straznicky, N. E
Right arrow Articles by Lambert, E. A
Agricola
Right arrow Articles by Straznicky, N. E
Right arrow Articles by Lambert, E. A
© 2009 American Society for Clinical Nutrition

ORIGINAL RESEARCH COMMUNICATION

Blunted sympathetic neural response to oral glucose in obese subjects with the insulin-resistant metabolic syndrome1,2,3

Nora E Straznicky, Gavin W Lambert, Kazuko Masuo, Tye Dawood, Nina Eikelis, Paul J Nestel, Mariee T McGrane, Justin A Mariani, Florentia Socratous, Reena Chopra, Murray D Esler, Markus P Schlaich and Elisabeth A Lambert

1 From the Human Neurotransmitters (NES, GWL, KM, TD, NE, MTG, FS, RC, MDE, MPS, and EAL) and Cardiovascular Nutrition Laboratories (PJN) and Heart Failure Division (JAM), Baker IDI Heart & Diabetes Institute, Melbourne, Victoria, Australia.

2 Supported by a Diabetes Australia Research Trust Grant and a Future Forum Research Grant (to NES), a Heart Foundation Grant-in-Aid, an NH & MRC Project Grant (472604) from the Australian Government, NHMRC Career Development Awards (to EAL and MS), an NHMRC Senior Research Fellowship (to GWL), and an NHMRC Senior Principal Research Fellowship (to MDE).

3 Reprints not available. Address correspondence to NE Straznicky, Human Neurotransmitters Laboratory, Baker IDI Heart & Diabetes Institute, PO Box 6492, St Kilda Road Central, Melbourne, Victoria 8008, Australia. E-mail: nora.straznicky{at}bakeridi.edu.au.

Background: Glucose ingestion stimulates sympathetic nervous system (SNS) activity in lean subjects, whereas blunted responses have been reported in the obese.

Objective: The objective was to investigate the impact of insulin resistance on the SNS response to oral glucose.

Design: Nineteen insulin-resistant (IR) and 12 insulin-sensitive (IS) obese subjects with the metabolic syndrome and matched for age, sex, and blood pressure participated. Simultaneous measurements of muscle sympathetic nerve activity (MSNA) by microneurography, whole-body norepinephrine spillover rate, cardiac baroreflex sensitivity (BRS), calf blood flow, and arterial blood pressure were made at baseline and 30, 60, 90, and 120 min after a 75-g glucose load.

Results: IR subjects had a higher insulin area under the curve from 0 to 120 min (AUC0–120: 13,468 ± 677 compared with 6399 ± 612 mU/L · min; P < 0.001), glucose AUC0–120 (P < 0.05), and resting MSNA (41 ± 3 compared with 31 ± 3 bursts/min; P = 0.03) than did IS subjects. MSNA and the norepinephrine spillover rate increased from baseline (by 29 ± 7% and 40 ± 13%, respectively; P ≤ 0.001 for both) in IS subjects after the glucose load. In contrast, there was a blunted and delayed sympathetic response in IR subjects. Cardiac BRS and diastolic blood pressure decreased, whereas calf blood flow increased after the glucose load and by a similar magnitude in both groups (P < 0.01). Body mass index, abdominal fat, and insulin AUC0–120 were independent (inverse) predictors of the SNS response.

Conclusions: IR subjects with the metabolic syndrome have a blunted SNS response to oral glucose compared with IS subjects with the metabolic syndrome, which is related to central adiposity and the insulin response but not to differences in skeletal muscle vasodilation or BRS.




This article has been cited by other articles:


Home page
Am. J. Clin. Nutr.Home page
R. D Jindal
Autonomic response to oral glucose in those with metabolic syndrome
Am. J. Clinical Nutrition, June 1, 2009; 89(6): 1947 - 1948.
[Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
N. E Straznicky and E. A Lambert
Reply to RD Jindal
Am. J. Clinical Nutrition, June 1, 2009; 89(6): 1948 - 1949.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by The American Society for Nutrition